Unknown Bones, Joints & Muscles NIHR-supported project Infection & Immunity
Effect of Filgotinib on rheumatoid arthritis synovial cells
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Peter Taylor (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
Effects of GSK1070806 (anti-IL18 mAb) on biomarkers in synovial tissue and blood of patients with rheumatoid arthritis.
A prospective, non-interventional study of the effectiveness, safety, and health related outcomes in patients with moderate to severe active rheumatoid arthritis receiving filgotinib
AlfaSigma - Profiling the effect of filgotinib on the suppression of clinical and subclinical inflammation in rheumatoid arthritis patients: a real world study of filgotinib use in moderate rheumatoid arthritis clinical services
Regulation of dendritic cell survival and function by synovial fibroblasts.
Role of cGAS-STING/IFN-I pathway in the establishment of synovial B-cells niches and response to B-cell depleting therapies in rheumatoid arthritis
Original classification
MusculoskeletalPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know